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ABSTRACT
The icsA gene of Shigella encodes a structural pro-
tein involved in colonization of the intestinal mucosa
by bacteria. This gene is expressed upon invasion of
the host and is controlled by a complex regulatory
circuit involving the nucleoid protein H-NS,
the AraC-like transcriptional activator VirF, and a
450nt antisense RNA (RnaG) acting as transcription-
al attenuator. We investigated on the interplay of
these factors at the molecular level. DNase I foot-
prints reveal that both H-NS and VirF bind to a
region including the icsA and RnaG promoters.
H-NS is shown to repress icsA transcription at
30 C but not at 37 C, suggesting a significant in-
volvement of this protein in the temperature-
regulated expression of icsA. We also demonstrate
that VirF directly stimulates icsA transcription and is
able to alleviate H-NS repression in vitro. According
to these results, icsA expression is derepressed in
hns- background and overexpressed when VirF is
provided in trans. Moreover, we find that
RnaG-mediated transcription attenuation depends
on 80nt at its 50-end, a stretch carrying the anti-
sense region. Bases engaged in the initial contact
leading to sense–antisense pairing have been
identified using synthetic RNA and DNA oligo-
nucleotides designed to rebuild and mutagenize
the two stem–loop motifs of the antisense region.
INTRODUCTION
Shigella is a highly adapted human pathogen that causes
the bacillary dysentery. This enteric syndrome, mainly
found in the developing world, is extremely contagious
and, although self-limiting, may be life threatening and
often fatal in children (1). Shigellosis is the result of the
coordinated action of several genes encoded by both the
large virulence plasmid (pINV) and the chromosome.
Upon host invasion, the primary event consequent to
the upshift of bacteria to the host temperature (37 C) is
the synthesis of two plasmid-encoded regulators: VirF and
VirB. First, VirF, an AraC-like activator, triggers a regu-
latory cascade involving the activation of the icsA and
virB genes. Then, VirB activates several operons-encoding
factors required to invade and colonize the intestinal
mucosa (2,3).
At this stage, an important virulence factor is repre-
sented by the IcsA protein (also known as VirG), which
sponsors the intra- and intercellular spread of bacteria (4).
IcsA is an outer membrane protein, which asymmetrically
accumulates at one pole of the bacterial cell, catalyzing the
direct elongation of an actin tail which propels Shigella
through the cytoplasm and facilitates the intercellular dis-
semination toward neighboring cells (5). Due to its prime
role in the invasion process, it is reasonable to expect
the regulation of the icsA gene to be a sophisticated multi-
layered process. VirF, the master activator of the plasmid-
encoded virulence cascade, has been shown to induce
the expression of icsA in vivo (2,6,7), although little is
known on its molecular mechanism. Another player in
the regulation of icsA is the nucleoid associated protein
H-NS, implicated in chromosome organization and also
acting as a global regulator (8–10). H-NS has been shown
to repress icsA at low temperature (11) and to speciﬁc-
ally interact with the icsA promoter (12). This protein
also binds and represses the transcription of virF and
virB as a function of temperature, playing a direct role
in silencing the Shigella virulence regulon outside the
host (13–16).
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sense RNA of  450nt, termed RnaG, controlling icsA
expression and transcribed in cis from the icsA sequence
(17). Small RNAs are emerging as a powerful tool in gene
regulation and particularly in modulating adaptive stress–
responses that are important for bacteria to survive within
the host (18–21). Different RNA–RNA-mediated mechan-
isms, entailing changes in processing and degradation of
the target messenger and alterations of the efﬁciency
of transcription and translation have been described
(22–24). RnaG regulates icsA transcription by two inde-
pendent mechanisms; transcriptional interference and
transcriptional attenuation. As for the ﬁrst mechanism,
we have recently shown that silencing of the RnaG
promoter results in a higher activity of the icsA promoter
(17). On the other hand, we have also shown that RnaG
represents the ﬁrst evidence of a RNA-mediated transcrip-
tional attenuation of a bacterial virulence gene. In fact,
binding of RnaG to the nascent icsA transcript induces
the formation of a stem–loop motif at the 50-end of the
mRNA, mimicking an intrinsic terminator and resulting in
the synthesis of a truncated icsA mRNA (17).
Here, we report on the identiﬁcation of the H-NS and
VirF-binding sites on the icsA and RnaG promoter
regions and on the in vivo and in vitro relevance of their
interactions on the expression of icsA. VirF directly stimu-
lates icsA transcription while H-NS contributes to the
thermoregulation of icsA, severely reducing its transcrip-
tion at 30 C. We also found that the RnaG-mediated
premature termination of the icsA transcript depends on
about 80 out of 120nt of the antisense region of RnaG. In
particular, by the use of synthetic RNA and DNA mol-
ecules and a site-speciﬁc mutagenesis approach, we have
been able to identify the RnaG regions initially contacting
with the icsA mRNA to form the so called kissing complex
and needed for the transcriptional attenuation.
MATERIALS AND METHODS
Bacterial strains and general procedures
Escherichia coli K12 strain HMG9 is a HMG11 derivative
defective in the hns gene. Strains ULS1127 and ULS1129
are P90C monolysogens for a   transducing phage carrying
aP icsA-lacZ transcriptional fusion with a functional or
a silenced PRnaG convergent promoter, respectively (17).
Proteins were expressed in E. coli strain BL21(DE3) con-
taining the pLysS plasmid (Promega).
Plasmid pMYSH6601 is a pBR322-derivative contain-
ing the virA-icsA region of S. ﬂexneri 2a pINV (31). A
478-bp icsA fragment (from positions  262 to +216)
was ampliﬁed by PCR using the primer pair GZ24/
ACC9 on the pMYSH6601 template and cloned into the
BamHI site of pKK232-8, thus obtaining plasmid
pKG450.
Plasmids pGT1127 is a pGEMT-easy derivative con-
taining a 866bp from the virA-icsA region ( 448 to
+419) of the S. ﬂexneri 2a. Plasmids pGT1129 and
pGT1083 contain the same fragment lacking the PRnaG
or PicsA promoter, respectively.
Plasmid pGT80T contains the ﬁrst 80bp of the
sequence-encoding RnaG followed by a transcription
termination signal. It has been obtained by cloning
into pGEMT-easy a fragment obtained by amplifying
pGT1127 DNA with the oligo pair G+120H/G40T (or
ACC9/G40T).
pMYSH6504 and pDIA510 plasmids are both pBR322
derivatives containing, respectively, the entire virF gene
from S. ﬂexneri 2a pINV (25) and the entire hns gene
from E. coli (26).
b-galactosidase assays were performed with sodium
dodecyl sulfate/chloroform-permeabilized cells grown in
LB medium supplemented with ampicillin. b-galactosidase
activity was determined as described by Miller (1992) (48)
and the results were expressed as averages of three inde-
pendent experiments.
Extraction of plasmid DNA, restriction digestion, elec-
trophoresis, PCR and puriﬁcation of DNA fragments
were carried out as described previously (16). RNA extrac-
tion was carried out as previously described by La Teana
et al. (27) except that hot phenol and chloroform:isoamyle
alcohol (24:1) extractions were performed in place of puri-
ﬁcation in CsCl.
Radioactivity associated with DNA or RNA was
detected and quantiﬁed by Molecular Imager (Bio-Rad,
mod. FX) and oligos used in this study are listed in
Supplementary Data and Table S1.
VirF puriﬁcation
To obtain overexpression of VirF, we constructed
pULS22F, a plasmid containing the entire virF gene of
S. ﬂexneri 2a. To this end, an amplicon obtained upon
PCR ampliﬁcation of the template plasmid pMYSH6504
DNA (25) with oligo pair FsinL and SW04 (modiﬁed to
contain NdeI or XhoI sites, respectively) was introduced
into the pET22b vector (Novagen) linearized by NdeI/
XhoI digestion. pULS22F was then transformed into
BL21(DE3) pLysS strain selecting for Ap
r. Expression of
the C-terminally His-tagged VirF protein was induced
with 1mM IPTG in exponentially growing 500ml of cul-
ture. Bacterial cells were then sonicated and the protein was
puriﬁed under native conditions using immobilized-metal
afﬁnity chromatography (IMAC) with a Ni–nitrilo-
triacetic acid-agarose column according to the manufac-
turer protocol (Qiagen). The protein was ﬁnally eluted as
1-ml fractions with 8-ml elution buffer (50mM Na2HPO4,
300mM NaCl, 10% Glycerol, 0.1% Tween-20, 10mM
b-mercaptoethanol) containing from 50 to 500mM imid-
azole. Fractions were analyzed by SDS–PAGE and those
containing the VirF protein were pooled and dialyzed
against 1l of 20mM Tris–HCl, pH 8, 30mM Na2HPO4,
50mM NaCl, 5% glycerol. The His-tagged wild type VirF
protein was found to be fully functional in vivo (data not
shown).
RnaG80 synthesis and puriﬁcation
Plasmid pTZRnaG80 was obtained by cloning 80nt of the
RnaG gene (from positions +40 to +120 with respect to
the icsA transcription start) into the HindIII/EcoRI re-
striction sites of pTZ19R, under the control of the T7
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using pGT1127 as DNA template and the primer G+120H
and G+40E. To synthesize RnaG80 transcript, pTZRnaG80
was linearized with EcoRI and used as template in an
in vitro transcription reaction with T7 RNA polymerase
as described by Brandi et al. (28).
DNase I footprinting
Supercoiled plasmids pKG673 (17) and pKG450 ( 150ng/
sample) were preincubated 5min at 25 C with the indicated
concentrations of H-NS or VirF in 30ml of binding buffer
(40mM HEPES–HCl, pH 8.0, 100mM KCl, 10mM mag-
nesium acetate and 0.5mM dithiothreitol). The DNA–
protein complex was incubated with 1U of DNase I for
40s. After stopping the reaction, the DNA was precipi-
tated and extended as described by Giangrossi et al. (29).
In vitro transcription
In vitro transcription from supercoiled plasmids ( 200ng/
sample) as DNA templates was carried out at 30 and at
37 C for 20min. Each reaction mixture (40ml) contained
40mM Tris–HCl, pH 7.5, 150mM KCl, 10mM MgCl2,
10mM dithiothreitol, 0.01% Triton X-100, 0.5mM each
of NTPs, 2U of ribonuclease inhibitor and 0.2U of E. coli
RNA polymerase (USB). The reaction was stopped on ice
and RNA was precipitated with ethanol in the presence
of 1mg tRNA as carrier. The transcription product
was detected by primer extension using a [g
32 P]-labeled
oligonucleotide essentially as described by Giangrossi
et al. (17).
Chemical RNA probing
Chemical modiﬁcation of RNA was performed as desc-
ribed by Giangrossi et al. (17) using the single-strand-
speciﬁc reagents DMS (A and C speciﬁc) and CMCT
(U and G speciﬁc). Control samples ( ) were treated iden-
tically with the exception that no modifying reagents were
added. The modiﬁed RNA was subjected to primer exten-
sion using the oligo G+40E.
RESULTS
H-NS and VirF modulate transcription of icsA and RnaG
by a direct interaction at promoter regions
Although H-NS and VirF are known to be involved in the
regulation of virulence genes in S. ﬂexneri (2,30), very little
is known on their role in the modulation of icsA expres-
sion, especially at the molecular level. While band shift
assays indicate that H-NS recognizes the icsA promoter
(12), no evidence supports a binding of VirF to the icsA
promoter region.
We investigated on the interaction of H-NS and VirF
with the regulatory region of icsA by DNase I footprint-
ing. H-NS protects three sites, numbered I, II and III and
centered at positions +25, +115 and +330, respectively
(Figure 1A and B), while VirF recognizes four regions,
numbered I, II, III and IV and centered at positions  3,
+62, +160 and +245, respectively (Figure 1C and D).
DNase I protected regions are reported on the icsA
sequence in Supplementary Figure S1 and are indicated
in the schematic map shown in Figure 1E.
H-NS-binding sites have an average length of  50bp
and, within the limit of accuracy of this type of analysis,
were bound with similar afﬁnities by H-NS
( 250–500nM). As opposed to other H-NS regulated
genetic systems, including the Shigella virulence genes
virB, virF and virA, where H-NS-binding sites have been
mapped on upstream regulatory regions (13–15), in the
case of the icsA promoter H-NS binds downstream the
transcriptional initiation site. Interestingly, H-NS site II
includes the  10 conserved promoter element of RnaG
whose occlusion might be relevant for transcriptional in-
hibition of PRnaG by H-NS (see below). VirF sites,
spanning from  40 to 60bp in length, are detectable at
low protein concentrations ( 80–130nM). VirF protec-
tion at site I covers the TATA box of PicsA and partially
overlaps the left end of H-NS site I, while the right end of
the latter site is superimposed on the VirF site II.
Moreover, H-NS bound to site II and VirF bound to
site III may contact the RnaG promoter (Figure 1E).
The position of H-NS and VirF-binding sites within the
icsA promoter region suggests that both genes icsA and
RnaG might be controlled by these regulators and
provides a physical basis for a possible functional compe-
tition between the two proteins. Initially, we analyzed the
effect of H-NS on the transcription of icsA and RnaG at
30 and 37 Ci na nin vitro system (Figure 2), using
plasmids pGT1127 (wt), pGT1129 (inactive PRnaG) and
pGT1083 (inactive PicsA) as DNA templates. The latter
two constructs carry mutations in the TATA box of
RnaG and icsA, respectively, therefore the transcription
of these genes is abolished. This allowed us to study the
transcription of these genes discriminating the effects
caused by H-NS from those due to the transcriptional
interference (TI) between the convergent promoters of
icsA and RnaG (17). At 30 C, H-NS is able to inhibit
transcription of both icsA and RnaG. Such repression is
more pronounced on PicsA than on PRnaG.A t 200nM
H-NS, the icsA mRNA is no longer detectable and tran-
scription attains <5% of the basal level obtained in the
absence of protein (Figure 2B and D). Double amounts of
H-NS (300–400nM) are required to produce a comparable
effect on RnaG transcription (Figure 2A and D). At 37 C,
H-NS almost completely loses its capacity to act as tran-
scriptional silencer, strongly suggesting that this protein
plays a key role in the temperature-dependent regulation
of icsA and RnaG genes. According to TI, the inactivation
of icsA promoter stimulates the transcriptional activity of
the convergent RnaG promoter. Under this condition of
hyper-expression, RnaG seems less susceptible to H-NS
repression even at 30 C. In fact, at 234 and 312nM
H-NS transcription is, respectively, 85 and 40% of the
level without protein (Figure 2C and D).
The VirF sites, localized on the icsA-RnaG locus,
involve regions relevant for the regulation of both the
icsA and the RnaG promoters (Figure 1E) and there is
evidence that VirF is needed to activate icsA expression
in vivo (7). By an in vitro assay, we succeeded in reproduc-
ing the VirF-mediated upregulation of icsA using the
puriﬁed protein. As shown in Figure 3A and C, at low
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strongly stimulated attaining an  10-fold peak at 17nM
VirF. Transcription returns to basal levels when an excess
of VirF is used (34 and 51nM), possibly due to VirF oc-
cupying all its target sites and to the consequent formation
of a transcriptionally inactive DNA–protein complex. As
opposed to icsA, transcription of RnaG displays a pro-
gressive decrease with increasing VirF concentration: the
activity of the RnaG promoter attains 58 and 22% in the
presence of 34 and 51nM VirF, respectively (Figure 3B
and C). Taken together, these results indicate that VirF is
able, depending on concentration, to stimulate PicsA and
repress PRnaG.
Since both H-NS and VirF bind the icsA-RnaG locus
(Figure 1), and antagonistically inﬂuence their transcrip-
tion (Figures 2 and 3), an active competition between
these regulators can be surmised. Therefore, this hypoth-
esis has been tested in vitro by monitoring icsA promoter
activity in the presence of both H-NS and VirF. The
results indicate that VirF is able to signiﬁcantly counteract
the H-NS-dependent inhibition, thus almost completely
relieving the transcriptional repression of icsA at the
lowest H-NS concentration tested (Supplementary
Figure S2).
H-NS and VirF modulate the in vivo expression of icsA
and RnaG
The in vitro functional assays (Figures 2 and 3) suggest
that H-NS is able to inhibit transcription of both icsA and
RnaG, as a function of temperature, while VirF behaves
as an activator of icsA. In addition, the basal activities of
PicsA and PRnaG (they are convergent and 120 nt apart) are
notcompletely independent, since these promoters respond
to transcriptional interference (TI) regulation (17). Hence,
we investigated on the possible interplay among H-NS,
VirF, temperature and TI in vivo. This was done by moni-
toring both the level of icsA mRNA and the expression of
b-galactosidase from PicsA-lacZ transcriptional fusions
carrying or lacking a functional PRnaG promoter
(Figure 4A and B).
Figure 1. H-NS and VirF show multiple binding sites on icsA regulatory region. Supercoiled plasmids pKG673 (A, C and D) and pKG450 (B),
containing the promoter and part of the coding region of icsA, were incubated at the indicated concentrations of either H-NS (A and B) or VirF (C
and D) expressed as dimer and monomer, respectively. Samples were processed as described in ‘Materials and methods’ section, using the oligos
GBA (A), ACC9 (B), G–100 (C) and G+370E (D) as primers. Lanes G, A and C represent the sequencing reactions using the same primers.
Protections and sites hypersensitive to DNase I are indicated by vertical lines and arrows, respectively. The diagram shows the icsA promoter region
from positions  100 to +390 (E). H-NS and VirF DNase I protections,  10 and  35 consensus elements, transcriptional start points of icsA and
RnaG (ts) and the icsA initiation triplet (ATG) are indicated.
Nucleic Acids Research, 2011,Vol.39, No. 18 8125The icsA promoter displays a natural thermoregulation
and its transcription is higher at 37 C (20A.U.) than at
30 C (11A.U.) also in cells lacking an active H-NS.
Moreover, a marked regulatory action can be attributed to
this protein since mutations of the hns gene cause a fur-
ther de-repression of icsA independently of temperature.
Indeed, when both icsA and RnaG are transcribed (i.e.
using plasmid pGT1127) the steady-state level of the
icsA mRNA in hns defective strains increases about
3-fold as compared to the wt (from 4 to 11A.U. at 30 C
and from 7 to 20A.U. at 37 C). In agreement with the
transcriptional pattern of the icsA mRNA, the activity of
the lacZ reporter gene in the E. coli strain ULS1127,
carrying a single chromosomal copy of the PicsA-lacZ
fusion, shows an  3-fold reduction in cells overproducing
H-NS from the pDIA510 plasmid. As expected, H-NS-
mediated repression is more pronounced at 30 C than at
37 C (Figure 4B). Similar conclusions about the role of
H-NS in the temperature-mediated regulation of icsA can
Figure 2. H-NS inhibits icsA and RnaG transcription. In vitro tran-
scription was carried out at 30 and 37 Co n 200ng of the supercoiled
plasmid templates pGT1127 (A), pGT1129 (B) and pGT1083 (C) in the
presence of the indicated concentrations of H-NS. The icsA and RnaG
transcripts were detected by primer extension using the oligos G+110
and G+50, respectively, and quantiﬁed by imager (D). The transcrip-
tion levels were normalized taking as 100%, the basal activity of the
promoter measured at 30 and 37 C, in absence of H-NS. Values of the
duplicated and/or tripled ‘0’ lanes were averaged and such value taken
as 100%. All points of each individual set of samples were expressed as
percentage of the corresponding ‘0’ samples. Lanes G and C represent
the sequencing reactions using the same primer.
Figure 3. VirF stimulates icsA and represses RnaG transcription. In
vitro transcription was carried out for 20min at 37 C on the super-
coiled plasmid templates pGT1129 (A) and pGT1083 (B) in presence of
the indicated concentrations of VirF. The icsA and RnaG transcripts
were detected essentially as described in Figure 2. Lanes G and C rep-
resent the sequencing reactions using the same primer. Radioactivity
associated with icsA and RnaG transcripts is plotted versus VirF con-
centration (C).
8126 Nucleic Acids Research, 2011,Vol.39, No. 18be drawn using the pGT1129 construct, which carries a
modiﬁed icsA regulatory region preventing RnaG synthe-
sis. Under these conditions, the basal activity of PicsA is
increased due to the absence of TI (compare hns
+ cells
transformed with pGT1129 or pGT1127 in Figure 4A).
Consistently, TI also accounts for the higher expression
of icsA in ULS1129 (an E. coli strain carrying a PicsA-lacZ
fusion with an inactivated RnaG promoter) as compared
to ULS1127. This is particularly evident in strains
overproducing neither H-NS nor VirF (Figure 4B). The
target of H-NS inhibition is mainly icsA rather than
RnaG, in agreement with the results shown in Figure 2.
Indeed, in an hns defective background, as an elevated
synthesis of icsA mRNA is achieved (11–20A.U.) RnaG
becomes undetectable (Figure 4A). It is reasonable to
assume that this is the outcome of TI, which leads to
decreased accessibility of PRnaG to RNA polymerase when
PicsA is overexpressed. Finally, as shown in Figure 4B,
providing VirF in trans by introducing plasmid
pMYSH6504, results in a stimulation of icsA expression.
This activation mainly takes place at 37 C and in strain
ULS1127, i.e. in the presence of a functional RnaG
promoter.
Establishment of a kissing complex between sense and
antisense RNAs mediates the transcriptional attenuation
of icsA by RnaG
To gain deeper insight into the transcriptional attenuation
mechanism governing the RnaG-mediated repression of
icsA, we have studied how RnaG interacts with its target
sequence on the icsA mRNA. RnaG is a 450nt sRNA. We
have demonstrated that its antisense region (RnaG120, i.e.
nucleotides 1–120) still preserves the ability to repress icsA
transcription in vitro, suggesting that this stretch consti-
tutes a single functional domain. In particular, RNA
probing showed that RnaG120 is highly structured and
is characterized by three stem–loop motifs, GH1, GH2
and GH3 (17) (Supplementary Figure S3).
To identify the RnaG regions promoting the initial
pairing with the icsA transcript, we ﬁrst shortened
RnaG120 by deleting 40nt at its 30-end, giving RnaG80.
This smaller variant was then subjected to chemical
probing using DMS and CMCT to verify whether the
extended deletion had caused an extensive modiﬁcation
of the native structure. As seen in Figure 5A and B, the
original structure of RnaG120 is essentially conserved in
RnaG80: the GH1 and GH2 motifs are still present and
structurally unchanged while the GH3 hairpin is lost.
This result prompted us to examine the ability of
RnaG80 to repress icsA transcription in vivo and
in vitro. First, we compared the entire RnaG (expressed
from pGT1083) to the shorter variant consisting of 80nt
(expressed from pGT80T) for their ability to inhibit the
expression of a chromosomal single-copy PicsA-lacZ fusion
(ULS119). As shown in Figure 6A both the full-length
RnaG and RnaG80, induce a comparable decrease of
b-galactosidase activity, supporting the repressive role of
the ﬁrst 80nt at the 50-end.
Next, an in vitro transcription assay was carried out in
the presence of RnaG80 using a plasmid template
(pGT1129) carrying the silenced RnaG promoter within
the icsA locus. The icsA mRNA was detected by primer
extension using an oligo recognizing only untruncated
transcripts (Figure 6B). Since binding of RnaG to icsA
mRNA can interfere with the elongation activity of the
reverse transcriptase (17), RnaG80 was added to the tran-
scription mixture either at beginning (samples B) or at the
end (samples E) of the reaction: this strategy allowed us to
Figure 4. Effect of H-NS and VirF on the in vivo expression of icsA.
(A) Escherichia coli wt (HMG11) and its isogenic hns- strain (HMG9)
harboring pGT1127 or pGT1129 plasmids were grown at 30 and 37 C
in LB broth to A600=0.5. Aliquots of each culture were processed for
total RNA extraction and 10mg of each sample were analyzed by
primer extension using the oligos G+50 and G+110 to detect RnaG
and icsA mRNA, respectively. (B) Esherichia coli strains ULS1127 and
ULS1129, carrying a wt hns gene (indicated with hns
+) and a
single-copy chromosomal PicsA-lacZ fusion with, respectively, a func-
tional RnaG promoter (PicsA/RnaG-lacZ) or a defective one (PicsA/
RnaGmut-lacZ), were used to assay b-galactosidase activity in the
presence of pMYSH6504 (a plasmid harboring the S. ﬂexneri virF
gene indicated with virF
+) or pDIA510 (a plasmid carrying extracopies
of the E. coli hns gene indicated with hns
+ +). Strains were grown in LB
broth at 30 or 37 Ct oA 600=0.4. The values represent the average of
at least three independent experiments and the standard deviation is
indicated.
Nucleic Acids Research, 2011,Vol.39, No. 18 8127Figure 5. Secondary structure at 50-end of RnaG. (A) Chemical probing of RnaG80 (nucleotides 1–80). Puriﬁed RnaG80 (2pmol) was treated
with increasing amounts of the single-strand speciﬁc reagents dimethyl sulfate (DMS) (0%, lanes 1 and 2; 0.22%, lane 3; 0.46%, lanes 4; 0.78%, lane
5) and 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene sulfonate (CMCT) (0mg/ml, lanes 6 and 7; 1.5mg/ml, lane 8; 3mg/ml, lane
9; 6mg/ml, lane 10) as described in ‘Materials and Methods’ section. Modiﬁed nucleotides were detected by primer extension using the oligo
G+40H and accessible sites were evaluated comparing samples incubated in the absence ( ) and in the presence of either DMS or CMCT.
Lanes C, T, A and G correspond to DNA sequencing ladders made with the same primer. (B) Schematic representation of the secondary structure
of RnaG80. Numbering is according to 50-end of the antisense RNA corresponding to position +120 on icsA sequence. Nucleotides reactive
to DMS or CMCT in Panel A are circled. Chemical probing data were superimposed on a computer prediction generated by the MFOLD
program (47).
Figure 6. RnaG80 is able to repress icsA expression. (A) The expression of a PicsA-lacZ fusion carried by E. coli strain ULS1129 was monitored in
cells transformed with pGT80T, pGT1083 or pGT1129 as control. The data (±SD) represent the average of three independent experiments.
(B) In vitro transcription was carried out at 37 C using 200ng of supercoiled plasmid pGT1129 as template. Increasing amounts of RnaG80
were added to the transcription mixture either at the beginning of the reaction (prior to RNA polymerase addition, samples B) or at the end
(immediately before RNA precipitation, samples E). The in vitro transcribed icsA mRNA was primer-extended with the oligo G+110.
8128 Nucleic Acids Research, 2011,Vol.39, No. 18discriminate the effect of the antisense RNA on transcrip-
tion initiation from that on cDNA elongation. The assay
showed that in the presence of low amounts of RnaG80
(up to 20fmol), the icsA mRNA level is lower in samples B
than in samples E. This result indicates that the shortened
RnaG speciﬁcally causes termination of the icsA trascript.
Higher amounts of RnaG80 (40fmol) are required to
interfere also with the detection of icsA mRNA by
primer extension. By plotting icsA transcription, expressed
as ‘sample B/sample E’ ratio, as a function of the amount
of RnaG80 (Figure 7F), it can be seen that the icsA
promoter activity attains 85, 64 and 34% at 5, 10 and
20fmol of RnaG80, respectively. Since RnaG80 conserves
its ability to properly function in vivo and in vitro, despite
the loss of the GH3 hairpin, we can conclude that this
motif is not required to interact with the icsA mRNA
and that the ﬁrst 80nt confer RnaG the complete capabil-
ity to teminate icsA transcription.
We then investigated which regions within RnaG80 play
a key role in establishing the initial contact with the icsA
Figure 7. Effects on icsA transcription of synthetic RNA and DNA oligonucleotides reproducing the structural motifs of RnaG. Secondary structure
of DNA oligos used to construct the GH1 (left) and GH2 (right) stem–loops of RnaG (A). Mutations carried by oligos GM18, GM30 and GM60 are
reported below the native sequence. In vitro transcription of icsA gene was performed, as described in the legend of Figure 6, using as templates the
pGT1129 (B, C and D) and the pGT1129M (E) which synthesizes the mutated icsA81/4 mRNA (17). The increasing amounts of RNA oligo pair
GR4–48/GR49–80 (B) and DNA oligo pairs G1–50/G49–80 (C and E) and G14–48/G49–80 (D) are indicated. After quantization, the radioactivity
associated with icsA mRNA is expressed as ratio sample B/sample E and values are plotted as percentage assuming 100% the transcription of DNA
template without oligos (F). Data from Figure 6B and from panels B, C, D and E are indicated with closed squares, open squares, closed triangles,
closed circles and open circles, respectively.
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DNA oligonucletides partially or entirely reproducing the
GH1 (oligos GR4–48, G1–50, G14–48 and G1–35) and
GH2 (oligos GR49–80, G49–80) motifs which characterize
the secondary structure of RnaG80 (Figures 5B and 7A).
The ability of these oligos to block the synthesis of the
icsA messenger was monitored by means of the previously
illustrated in vitro transcription assay. While none of the
oligos was individually able to affect icsA transcription
(not shown), we found that the use of the RNA oligo
pair GR4–48/GR49–80, which fully reconstructs RnaG80,
inhibits trascription even more severely (60 and 41% at
5 and 10fmol of oligos, respectively) than the puriﬁed
RnaG80 (Figure 7B and F). Likewise, alternatively
combining the DNA oligos G1–50 and G14–48 with
G49–80 caused a reduction of icsA transcription, compar-
able to that observed with the RNA oligos (Figure 7C, D
and F), suggesting that the secondary structure, rather
than the nature of the molecule, is essential in determining
the RnaG-mediated transcriptional repression. Recently,
we showed that mutations on icsA gene (from positions 81
to 84) abolish the transcriptional attenuation by dest-
abilizing the intrinsic terminator triggered on the nascent
mRNA by the sense–antisense interaction (17). As
expected, the oligo pair G1–50/G49–80 is almost totally
inactive in repressing transcription from a plasmid carry-
ing the icsA81/4 mutation (Figure 7E and F), which im-
pedes the formation of the RnaG-mediated icsA mRNA
terminator.
Altogether these results indicate that the minimum size
necessary to maintain the RnaG attenuation activity on
icsA is  65nt spanning from positions 14 to 80 and that
both motifs, GH1 and GH2, are required. To further learn
about which portions within this region primarily contrib-
ute to recognize the icsA mRNA, we used DNA oligos
carrying base-exchanges localized at the level of
unpaired nucleotides (apical loops and bulge) of the
GH1 (oligos GM18 and GM30) and GH2 (oligo GM60)
hairpins (Figure 7A). In vitro transcription assays were set
up using each mutated GH1 or GH2 oligo in combination,
respectively, with the wt GH2 (G49–80) or GH1 (G1–50)
oligos, so as to cover the entire RnaG80 sequence. While
the GM18 oligo conserves a residual repressive activity,
GM30 and GM60 mutations completely abate the ability
of these synthetic DNA molecules to terminate icsA tran-
scription, suggesting that unpaired bases at the apical
loops GH1 (nucleotides 30–33) and GH2 (nucleotides
60–64) provide the primary nucleation points, known as
kissing complex, for sense–antisense RNAs pairing
(Supplementary Figure S4 and Figure 8).
DISCUSSION
The actin-based motility of Shigella, the causative agent of
bacillary dysentery, depends on IcsA, an outer membrane
protein that accumulates at one pole of the bacterial cell
(4). IcsA is capable of directly recruiting and activating
host cell factors, thus catalyzing the assembly of an actin
tail which provides the propulsive force for intracellular
movement and intercellular dissemination of bacteria
through the human intestinal epithelium (5).
As is the case for other Shigella virulence genes, also the
icsA gene is located on the large virulence plasmid (pINV)
typically harbored by this pathogen (31). Over the years,
evidence has built up indicating that the regulation of icsA
depends on the nucleoid protein H-NS, which acts as a
repressor, and on the AraC-like protein VirF, the major
activator of the Shigella invasivity regulon (7,11,12).
Nevertheless, the molecular details of this regulatory mech-
anism have remained elusive. We have recently shown that
an additional player is involved: RnaG, a non-coding
sRNA which acts as an antisense regulator on the icsA
transcript (17). This study is an attempt to clarify the
interplay among these factors in order to evaluate their
contribution to the expression of icsA, not only as
Figure 8. Identiﬁcation of stem–loop motifs involved in the formation
of the kissing complex between RnaG and icsA mRNA. Schematic
representation of the three regions (arrows) providing the initial nucle-
ation points for the pairing of RnaG80 and icsA mRNA. Interactions
occur between GH2 (positions 60–63) and AH1 (positions 59–62), as
well as between GH1 (positions 18–23 and 30–36) and AH2 (positions
98–103 and 85–91).
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and integrated regulatory circuit.
H-NS modulates the expression of  5% of the E. coli
genome. Approximately one-third of these genes are
linked to the adaptation of bacteria to stress conditions
and to the regulation of pathogenicity processes (9,32–34).
Actually, it is emerging that H-NS partecipates to the
regulation of many genes whose expression is sensitive
to temperature shifts and speciﬁcally to the virulence
genes of Shigella. For example it has been found that
H-NS represses transcription of virF, the primary regula-
tor of the invasivity functions, at 30 C but not at 37 C
(14,16). In the present study, we have shown that H-NS
can also silence the virulence gene icsA in a temperature-
dependent manner (Figures 2 and 4). This effect, exerted
at the transcriptional level, is likely achieved through a
temperature-mediated occupancy by H-NS of its binding
sites on the icsA promoter region (Figure 1). This hypoth-
esis is supported by the unsuccessful attemps to obtain
clear protections by H-NS in footprints carried out at
37 C (Supplementary Figure S5).
Unlikely to other H-NS-regulated genes, in which bind-
ing sites have been mostly identiﬁed on the upstream regu-
latory regions (8,35), the three H-NS recognition sites on
the icsA promoter are located downstream the icsA tran-
scription start. Interstingly, two sites reside in the DNA
tract between icsA and the RnaG promoters (Figure 1E).
This arrangement likely favors the repressive action of
H-NS on both icsA and RnaG genes. Indeed, the
transcription of both genes is reduced by the presence of
H-NS (Figure 2). The inhibition is more pronounced on
icsA, suggesting that it may represent a preferential target
as compared to RnaG. Nonetheless, the ability of H-NS to
repress also a sRNA promoter further stresses the signiﬁ-
cance of this nucleoid protein as global regulator. It is not
surprising that H-NS and sRNA molecules cooperate,
since both are known to regulate bacterial gene expression
in reponse to stress conditions (23,35). In this context, it is
worth mentioning that the translation of the hns mRNA
itself is controlled by DsrA, a sRNA (36). Moreover,
DsrA can also counteract the H-NS silencing of rcsA, a
regulatory gene involved in the synthesis of the capsular
polysaccharide in E. coli (37). Recently, H-NS was also
found to directly activate translation of several E. coli
mRNAs with non-canonical Shine Dalgarno sequences
(38), further supporting the view that signiﬁcant connec-
tions exist between this nucleoid protein and the RNA
world.
Besides icsA promoter, additional four H-NS-binding
sites have been found on the regulatory region of virA,
another important virulence gene responsible for destroy-
ing host cell microtubules (39). Notably, virA is located
 360nt upstream icsA in the reverse orientation. These
four H-NS binding sites, spanning from positions  220
to  350, possibly mediate the negative regulation of virA
by H-NS (15). The icsA gene shows a high degree of in-
trinsic bending (12) and the center of curvature of the
icsA-virA intergenic region has been located around
position  70 (G. Micheli, personal comunication).
According to the preferential interaction of H-NS with
bent DNA (40), it is conceivable that the curvature
ﬂanked by multiple target sites might provide a nucleation
point for protein oligomerization, resulting in the occlu-
sion of the entire virA-icsA region to RNA polymerase.
This hypothesis is supported by the fact that both icsA and
virA are derepressed in hns- cells [Figure 4 and (15)]. The
intrinsically curved DNA, localized between virA and icsA
genes, might respond to temperature shifts, thereby
controlling the binding of H-NS as demonstrated in the
regulation of virF (14,16). Alternatively, it has been
proposed that a thermal increase causes modiﬁcations in
the quaternary structure of H-NS, leading to the decrease
of high-order oligomers versus the appearance of discrete
dimers. Such conformational change, in turn, would
reduce the ability of H-NS to bind DNA (41). However,
this issue has not been settled conclusively since a large
number of H-NS-repressed genes remain silenced at 37 C,
suggesting that a simple effect of temperature on the state
of aggregation of H-NS cannot account for the
temperature-dependent derepression of this subset of
genes. Moreover, opposed to the temperature-mediated
aggregation model, H-NS oligomerization has been
reported to be constant in the range 28–42 C (33).
Our data reveal that, besides H-NS, also VirF is able to
speciﬁcally interact with the icsA-RnaG region, by recogn-
izing four biding sites (Figure 1) and it plays a direct role
in activating icsA transcription (Figure 3). In vivo data
indicate that VirF is able to stimulate icsA expression at
37 C and that this also occurs at 30 C, albeit to a much
lesser extent (Figure 4). In most cases, VirF does not bind
to only one site but rather simultaneously interacts with
two sites. By different footprinting techniques, the 13-bp
conserved sequence TTTaGYcTtTat (nucleotides with a
frequency  60% in the consensus sequence are in upper-
case and Y indicates pyrimidines) was found in VirF pro-
tected regions and it has been proposed that VirF tightly
binds to this sequence when present as an inverted repeat
and weakly when the sequence is present only once (49).
Although the mechanism adopted by VirF to activate
transcription is still questionable, VirF bound at its site
I, which includes the  10 conserved element, presumably
contacts the RNA polymerase thus facilitating its access
to the icsA promoter. This condition can occur assuming
that ﬁrst VirF preferentially interacts with a high afﬁnity
site (i.e. site III). Subsequently, the occurrence of DNA
looping, which is commonly involved in the AraC-
mediated regulation (50), may favor the contact of VirF
with the promoter proximal site I. This hypothesis is vali-
dated by some facts: (i) this two step binding model has
been described in the regulation of yop genes of Yersinia
by VirF (49); (ii) protection at VirF site III is quite
pronounced even with the lowest concentrations of VirF
used (42–84nM VirF, Figure 1C and D), indicating that
this site might be the ﬁrst to be occupied by the protein;
(iii) three regions, showing a high homology with the
13-bp consensus motif and inversely orientated, are present
within VirF site III while only one or two have been found
within sites I, II and IV (Supplementary Figure S1). This
binding pathway can also explain repression of transcrip-
tion by VirF. In fact, progressive ﬁlling-in of all available
sites, as a function of protein amount, might cause the
formation of a VirF–DNA complex covering a wide
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promoters. This, in turn, would block transcription by
trapping the RNA polymerase. Besides acting at the tran-
scriptional level by directly stimulating PicsA, VirF in-
creases IcsA expression by two additional strategies:
(i) reduction of the intracellular level of RnaG, as observed
in vivo by analyzing PRnaG-lacZ fusions (data not shown);
(ii) lowering of the frequency of transcription initiation at
PRnaG thus affecting the extent of transcriptional interfer-
ence (TI) between RnaG and icsA. These mechanisms are
direct consequences of the repressive action exerted by
VirF on PRnaG. We have previously shown that TI
occurs between the convergent RnaG and icsA promoters
(17). Hence, VirF would limit the transit events and con-
sequently the occupancy of PicsA by elongation complexes
moving from the convergent PRnaG, thus enabling icsA
mRNA synthesis.
VirF binding sites I and II are partially overlapping the
H-NS box I while the VirF site III is adjacent to the H-NS
box II (Figure 1E). Such an organization of target sites on
the icsA promoter is consistent with a possible competi-
tion between the icsA-activating VirF and the repressing
H-NS. Since virF expression rapidly increases when tem-
perature is raised >32 C (14) and H-NS is able to recog-
nize the icsA-RnaG region only at lower temperature, it
could be argued that VirF and H-NS do not interfere with
each other because their opposite action on icsA promoter
is, somehow, spaced by a gap of temperature. On the con-
trary, transcriptional competition assays between VirF
and H-NS reveal that, in the presence of H-NS, VirF is
capable to restore, albeit not completely, the basal activity
of PicsA (Supplementary Figure S2), thus proposing a
more complex scenario. As the temperature raises, the
interaction of VirF with sites I, II and III may disrupt the
H-NS-stabilized complex by forming a putative H-NS-
icsA-VirF intermediate, thus promoting a switch from a
repressed to an activated state. In agreement with this ob-
servation, an antagonistic role between H-NS and VirF
has been found in the regulation of virB (13).
Regulatory antagonism between H-NS and members of
the AraC-like protein family is emerging as a common
strategy that bacterial pathogens adopt to control the
virulence genes [reviewed in (42)], as exempliﬁed, for
instance, by (i) the V. cholerae TCP system, essential for
the biogenesis of the toxin-co-regulated pilus (ToxT/
H-NS) (43); (ii) the E. coli gad genes, involved in the
adaptative response to acid stress (GadX/H-NS) (29);
(iii) the ler gene of enteropathogenic E. coli, required to
initiate the regulatory cascade activating the LEE locus
(PerA/H-NS) (44). While the AraC-like protein represents
the primary regulator, the involvement of H-NS might
also reﬂect the need to ﬁne-tune gene expression adapting
it to the environmental changes that bacterial cells face
upon host invasion (32,45).
The interplay between VirF and H-NS in the regulation
of icsA is made more complex by the presence of RnaG,
one of the largest (450nt) non-coding RNAs in bacteria.
We have shown that RnaG is a cis-encoded antisense
RNA whose 120nt at the 50-end (RnaG120) are comple-
mentary to the 50-UTR icsA transcript and behave as a
functional domain inducing premature termination of the
icsA mRNA by transcriptional attenuation (17). In
general, the initial sense–antisense RNA contact, also
known as kissing complex, takes place between two com-
plementary loops (multistep pathway) or between a loop
and a single-stranded region (one-step pathway). In both
cases, such interactions, each one involving 4–7 exposed
nucleotides, lead to a helix progression until a fully paired
RNA is formed (22,46). We have recently described the
secondary structure of RnaG120 and of the 50-end
( 150nt) of the icsA mRNA (17); while the ﬁrst is
characterized by three hairpin structures, GH1, GH2
and GH3, the latter only shows two structural motifs,
AH1 and AH2 (Figure 8 and Supplementary Figure S3).
In the present study, we demonstrate that only GH1 and
GH2 participate in establishing the kissing complex
between RnaG and icsA mRNA, thus forming a function-
al domain responsible for icsA regulation by RnaG. This
conclusion is supported by several lines of evidence.
In vitro and in vivo experiments (Figure 6) indicate that
out of 120nt at the 50-end of RnaG, the initial 80nt
(RnaG80) represent the minimum stretch able to repress
icsA transcription. This ﬁnding is in agreement with the
observation that a limited number of base pairs and not
full-duplex formation between sense and antisense RNAs
is usually required for control as shown in the case of R1,
ColE1 and pIP501 (22). Despite the lack of GH3 in
RnaG80, the secondary structures of GH1 and GH2
(Figure 5) are conserved in RnaG120 (Supplementary
Figure S3), as well as at the 50-end of the entire RnaG
(not shown), stressing the relevance of the spatial organ-
ization of RnaG for its function. The need for both motifs,
GH1 and GH2, is also evidenced by the ﬁnding that syn-
thetic molecules carrying either GH1 or GH2 are unable
to terminate icsA transcription and that this ability is
restored as the native structure of RnaG80 is reconstituted
by aligning the two motifs head-to-tail using suitable
oligos (Figure 7). Termination of icsA mRNA, however,
does not depend on the nature of the oligo molecule used
(DNA or RNA).
The analysis of icsA mRNA and 50-end of RnaG struc-
tures reveals the following potential points of interaction:
(i) the apical loop of GH2 can pair with the basal bulge of
AH1; (ii) the apical loop and the internal bulge of GH1
can anneal with the structurally similar motifs of AH2
(Figure 8). The relevance of contact points emerges from
experiments using mutated RnaGs. Changing the exposed
bases on the GH1 and GH2 loops to hinder their pairing
with the complementary icsA mRNA regions, affects the
repression activity of RnaG (Supplementary Figure S4).
Complete inactivation occurs with the GM30 and GM60
mutations, indicating that these stretches of bases are es-
sential for the formation of the kissing complex. Pairing
might follow a two-step binding pathway, starting at the
critical sequence of either the GH1 or the GH2 loop and
using the remaining loop–loop interaction as nucleation
site for RNA duplex propagation. Instead, GM18
mutation only partially alters RnaG functioning, suggest-
ing that the internal bulge of GH1 may have an auxiliary
role in establishing the early contact between the GH1 and
AH2 structural motifs. Irrespective of the binding kinetics
and loop–loop initiating system, the functional
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model based on the formation of an intrinsic terminator
on the nascent icsA mRNA, triggered by the sense–anti-
sense pairing (17). Indeed, both native and synthetic
molecules carrying the 50-end of RnaG fails to halt tran-
scription of the icsA81/4 mRNA in which a four bases
mutation in the stem of the terminator impedes the for-
mation of an intramolecular RNA duplex (Figure 7 and
data not shown).
Besides the relevance of IcsA as a virulence determin-
ant, the fact that its expression is themoregulated and
ﬁnely controlled by VirF, H-NS and the antisense RnaG
makes this gene a very interesting candidate to compre-
hend how complicated regulatory circuits are functioning
and how they have evolved. The aim of the present study
has been to address some crucial points of this regulation,
particularly those related to the antagonism between the
two regulators VirF and H-NS and to their interplay with
RnaG. Furthermore, icsA offers a chance to clarify several
molecular aspects of sense–antisense pairing providing
insights into the rules driving the formation of the
kissing complex and, more generally, into the mechanisms
of riboregulation.
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